Medical device maker AngioDynamics fights rival’s ‘extraordinary’ trial bill
Defendant C.R. Bard Inc prevailed at antitrust trial and seeks travel and other expenses AngioDynamics has appealed verdict to 2nd U.S. Circuit (Reuters) – Health care technological know-how corporation AngioDynamics…
/cloudfront-us-east-2.images.arcpublishing.com/reuters/D7MNLKNPJVPETENLDKBKOKYNKY.jpg?ssl=1)





